- Home
- HLP vs ICCM Comparison
HLP vs ICCM Comparison
Compare HLP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- ICCM
- Stock Information
- Founded
- HLP 2021
- ICCM 2006
- Country
- HLP China
- ICCM Israel
- Employees
- HLP N/A
- ICCM N/A
- Industry
- HLP Industrial Machinery/Components
- ICCM
- Sector
- HLP Industrials
- ICCM
- Exchange
- HLP Nasdaq
- ICCM Nasdaq
- Market Cap
- HLP 65.3M
- ICCM 59.9M
- IPO Year
- HLP 2023
- ICCM N/A
- Fundamental
- Price
- HLP $0.68
- ICCM $1.05
- Analyst Decision
- HLP
- ICCM Strong Buy
- Analyst Count
- HLP 0
- ICCM 1
- Target Price
- HLP N/A
- ICCM $2.50
- AVG Volume (30 Days)
- HLP 152.7K
- ICCM 347.5K
- Earning Date
- HLP 05-12-2025
- ICCM 08-19-2025
- Dividend Yield
- HLP N/A
- ICCM N/A
- EPS Growth
- HLP N/A
- ICCM N/A
- EPS
- HLP N/A
- ICCM N/A
- Revenue
- HLP $14,105,620.00
- ICCM $3,273,000.00
- Revenue This Year
- HLP N/A
- ICCM $83.41
- Revenue Next Year
- HLP N/A
- ICCM $185.02
- P/E Ratio
- HLP N/A
- ICCM N/A
- Revenue Growth
- HLP N/A
- ICCM 0.34
- 52 Week Low
- HLP $0.63
- ICCM $0.48
- 52 Week High
- HLP $2.13
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- HLP 30.74
- ICCM 51.32
- Support Level
- HLP $0.72
- ICCM $0.96
- Resistance Level
- HLP $0.78
- ICCM $1.17
- Average True Range (ATR)
- HLP 0.08
- ICCM 0.08
- MACD
- HLP -0.01
- ICCM 0.01
- Stochastic Oscillator
- HLP 3.67
- ICCM 63.89
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.